Robert L. Dow

Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

Jeffrey H. Hanke, Joseph P. Gardner, Robert L. Dow et al. · Journal of Biological Chemistry · 1996 · 1.9K citations · Full text

Total synthesis of the polyether antibiotic ionomycin

David A. Evans, Robert L. Dow, Thomas L. Shih et al. · Journal of the American Chemical Society · 1990 · 235 citations

Bioorganic Chemistry, Antibiotic Adjuvant, Altmetric Attention Score +18

Aldol addition reactions of chiral crotonate imides

David A. Evans, Eric B. Sjogren, Javier Bartrolí et al. · Tetrahedron Letters · 1986 · 123 citations

Chiral Crotonate Imides, Stereoselective Synthesis, Pharmacology +2

Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1

Robert L. Dow, Jiancheng Li, Michael P. Pence et al. · ACS Medicinal Chemistry Letters · 2011 · 100 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Pharmaceutical Chemistry +16

Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TRβ subtype-selective thyromimetics

Robert L. Dow, Steven R. Schneider, Ernest S. Paight et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 93 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Novel Series +7